Sandrine Piguel

Title: Sandrine Piguel: Innovator in Proteasome Modulation

Introduction

Sandrine Piguel is a notable inventor based in Massy, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate proteasome activity. Her work has implications for various diseases, showcasing her innovative spirit and dedication to advancing medical science.

Latest Patents

Sandrine Piguel holds 1 patent for her invention titled "Compounds useful as modulators of the proteasome activity." The patent describes compounds of a specific general formula that can be utilized as modulators of proteasome activity. These compounds are valuable in the preparation of medications aimed at preventing or treating diseases where the proteasome plays a critical role. Such diseases include inflammatory processes, various hematological and solid tumor cancers, immunological and autoimmune diseases, cardiac pathologies, myopathies, AIDS, cystic fibrosis, Alzheimer's, and Parkinson's disease. Additionally, these compounds can be used in cosmetic and phytosanitary compositions.

Career Highlights

Throughout her career, Sandrine has worked with prestigious institutions, including Université Pierre et Marie Curie and the Centre National de la Recherche Scientifique. Her research has been pivotal in understanding the role of proteasomes in disease mechanisms and therapeutic interventions.

Collaborations

Sandrine has collaborated with esteemed colleagues such as Michèle Claude Yvonne Reboud-Ravaux and Joëlle Vidal. These partnerships have enriched her research and contributed to the advancement of her innovative work.

Conclusion

Sandrine Piguel's contributions to the field of proteasome modulation highlight her role as a leading inventor in medicinal chemistry. Her innovative compounds have the potential to impact the treatment of various diseases significantly.